MDS Technology Receives Award Recognition

Protein analysis company Fluidics Analytics received a prestigious product award at the recent SLAS Europe Conference for its Fluidity One-W instrument, launching later this year. The technology offers the ability to assess on-target protein interactions in solution, even in crude biological backgrounds such as cell lysates or blood plasma, allowing researchers to attain detailed analyses of proteins in near-native states and in natural environments.

This capability, achieved through the company’s proprietary diffusional sizing technology, is based on the well-understood relationship between size and diffusion rate, yielding absolute size measurements and confirming the identity of complexes.

Andrew Lynn, Chief Executive Officer at Fluidic Analytics said: “It’s really exciting to see our diffusional sizing technology being recognised with high-profile awards and to be helping scientists in an increasing number of great research projects each day. Our goal at Fluidic Analytics is to enable a better understanding of proteins and protein interactions for better decision-making; so scientists can ensure that their work has the greatest impact. The launch of the Fluidity One-W is an important step towards this goal, providing scientists with new capabilities to accurately study a range of challenging proteins and protein interactions that couldn’t be accurately studied before. We believe that these new capabilities will facilitate significant advancements in human health, such as identifying new therapeutic avenues for Alzheimer’s disease – one of the high-impact areas already benefitting from our technology.”

The award is the latest in a string of recognition for the company’s microfluidic diffusional sizing (MDS) technology, including a spot in the Top 10 Innovations from The Scientist in 2018.